FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ken Ong

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Kathryn Beardsall; Sophie Vanhaesebrouck; Amanda L Ogilvy-Stuart; Christine Vanhole; Chris R Palmer; Ken Ong; Mirjam vanWeissenbruch; Paula Midgley; Mike Thompson; Marta Thio; Luc Cornette; Iviano Ossuetta; Isabel Iglesias; Claire Theyskens; Miranda de Jong; Bryan Gill; Jag S Ahluwalia; Francis de Zegher; David D Dunger
Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study.
Ken Ong; Francis de Zegher; Carme Valls; David D Dunger; Lourdes Ibáñez
Persisting benefits 12-18 months after discontinuation of pubertal metformin therapy in low birthweight girls.
Germán Iñiguez; Ken Ong; Rodrigo A Bazaes; Alejandra Avila; Teresa Salazar; David D Dunger; Verónica Mericq
Longitudinal changes in insulin-like growth factor-I, insulin sensitivity, and secretion from birth to age three years in small-for-gestational-age children.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ken Ong (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Kathryn Beardsall; Sophie Vanhaesebrouck; Amanda L Ogilvy-Stuart; Christine Vanhole; Chris R Palmer; Ken Ong; Mirjam vanWeissenbruch; Paula Midgley; Mike Thompson; Marta Thio; Luc Cornette; Iviano Ossuetta; Isabel Iglesias; Claire Theyskens; Miranda de Jong; Bryan Gill; Jag S Ahluwalia; Francis de Zegher; David D Dunger
Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study.
The Journal of pediatrics 2010;157(5):715-9.e1-3.
2007: Ken Ong; Francis de Zegher; Carme Valls; David D Dunger; Lourdes Ibáñez
Persisting benefits 12-18 months after discontinuation of pubertal metformin therapy in low birthweight girls.
Clinical endocrinology 2007;67(3):468-71.
2006: Germán Iñiguez; Ken Ong; Rodrigo A Bazaes; Alejandra Avila; Teresa Salazar; David D Dunger; Verónica Mericq
Longitudinal changes in insulin-like growth factor-I, insulin sensitivity, and secretion from birth to age three years in small-for-gestational-age children.
The Journal of clinical endocrinology and metabolism 2006;91(11):4645-9.
2006: Lourdes Ibáñez; Ken Ong; Carme Valls; Maria Victoria Marcos; David D Dunger; Francis de Zegher
Metformin treatment to prevent early puberty in girls with precocious pubarche.
The Journal of clinical endocrinology and metabolism 2006;91(8):2888-91.
2006: Lourdes Ibáñez; Ken Ong; David D Dunger; Francis de Zegher
Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children.
The Journal of clinical endocrinology and metabolism 2006;91(6):2153-8.
2006: Lourdes Ibáñez; Carme Valls; Ken Ong; David D Dunger; Francis de Zegher
Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty.
The Journal of clinical endocrinology and metabolism 2006;91(6):2068-73.
2006: Ulf Ekelund; Ken Ong; Yvonne Linné; Martin Neovius; Søren Brage; David D Dunger; Nicholas J Wareham; Stephan Rössner
Upward weight percentile crossing in infancy and early childhood independently predicts fat mass in young adults: the Stockholm Weight Development Study (SWEDES).
The American journal of clinical nutrition 2006;83(2):324-30.
2005: Lourdes Ibáñez; Alina Fucci; Carme Valls; Ken Ong; David D Dunger; Francis de Zegher
Neutrophil count in small-for-gestational age children: contrasting effects of metformin and growth hormone therapy.
The Journal of clinical endocrinology and metabolism 2005;90(6):3435-9.
2005: Ken Ong
Adrenal function of low-birthweight children.
Endocrine development 2005;8():34-53.
2004: Germán Iñiguez; Néstor Soto; Alejandra Avila; Teresa Salazar; Ken Ong; David D Dunger; Verónica Mericq
Adiponectin levels in the first two years of life in a prospective cohort: relations with weight gain, leptin levels and insulin sensitivity.
The Journal of clinical endocrinology and metabolism 2004;89(11):5500-3.
2004: David D Dunger; Ken Ong
Abundance of adiponectin in the newborn.
Clinical endocrinology 2004;61(4):416-7.
2004: Lourdes Ibáñez; Carme Valls; Maria Victoria Marcos; Ken Ong; David D Dunger; Francis de Zegher
Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.
The Journal of clinical endocrinology and metabolism 2004;89(9):4331-7.
2004: David D Dunger; Kevin C J Yuen; Ken Ong
Insulin-like growth factor I and impaired glucose tolerance.
Hormone research 2004;62 Suppl 1():101-7.
2004: Lourdes Ibáñez; Angela Ferrer; Ken Ong; Rakesh Amin; David D Dunger; Francis de Zegher
Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
The Journal of pediatrics 2004;144(1):23-9.
2003: Neus Potau; Rachel Williams; Ken Ong; Carmen Sánchez-Ufarte; Francis de Zegher; Lourdes Ibáñez; David D Dunger
Fasting insulin sensitivity and post-oral glucose hyperinsulinaemia related to cardiovascular risk factors in adolescents with precocious pubarche.
Clinical endocrinology 2003;59(6):756-62.
2003: Lourdes Ibáñez; Ken Ong; Angela Ferrer; Rakesh Amin; David D Dunger; Francis de Zegher
Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
The Journal of clinical endocrinology and metabolism 2003;88(6):2600-6.
2003: Rakesh Amin; Carl Schultz; Ken Ong; Jan Frystyk; R Neil Dalton; Les Perry; Hans Ørskov; David D Dunger
Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study.
Diabetes care 2003;26(5):1456-61.
2003: Chiao-Chien Connie Hung; I Sadaf Farooqi; Ken Ong; Jian'an Luan; Julia M Keogh; Marcus E Pembrey; Giles S H Yeo; David D Dunger; Nicholas J Wareham; Stephen O' Rahilly
Contribution of variants in the small heterodimer partner gene to birthweight, adiposity, and insulin levels: mutational analysis and association studies in multiple populations.
Diabetes 2003;52(5):1288-91.
2003: Lourdes Ibáñez; Ken Ong; Francis de Zegher; Maria Victoria Marcos; Luis del Rio; David D Dunger
Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche.
Clinical endocrinology 2003;58(3):372-9.
2002: Germán Iñiguez; Ken Ong; Verónica Peña; Alejandra Avila; David D Dunger; Verónica Mericq
Fasting and post-glucose ghrelin levels in SGA infants: relationships with size and weight gain at one year of age.
The Journal of clinical endocrinology and metabolism 2002;87(12):5830-3.
2002: Kevin C J Yuen; D Cook; Ken Ong; P Chatelain; Linda Fryklund; P Gluckman; Michael B Ranke; Ronald G Rosenfeld; David D Dunger
The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults.
Clinical endocrinology 2002;57(3):333-41.
2002: Lourdes Ibáñez; Carme Valls; Angela Ferrer; Ken Ong; David D Dunger; Francis de Zegher
Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
The Journal of clinical endocrinology and metabolism 2002;87(6):2870-4.
2002: Kevin C J Yuen; Ken Ong; Sandra Husbands; Pierre Chatelain; Linda Fryklund; Peter Gluckman; Michael B Ranke; David Cook; Ronald G Rosenfeld; John Wass; David D Dunger
The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults.
The Journal of clinical endocrinology and metabolism 2002;87(5):1989-95.
2002: Ken Ong; Jürgen Kratzsch; Wieland Kiess; David D Dunger
Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate.
The Journal of clinical endocrinology and metabolism 2002;87(3):1041-4.
2002: Lourdes Ibáñez; Carles Aulesa; Neus Potau; Ken Ong; David D Dunger; Francis de Zegher
Plasminogen activator inhibitor-1 in girls with precocious pubarche: a premenarcheal marker for polycystic ovary syndrome?
Pediatric research 2002;51(2):244-8.
2002: David D Dunger; Lynn Ahmed; Ken Ong
Growth and body composition in type 1 diabetes mellitus.
Hormone research 2002;58 Suppl 1():66-71.
2002: Francis de Zegher; Ken Ong; Maria van Helvoirt; Angelica Mohn; Kathryn A Woods; David D Dunger
High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity.
The Journal of clinical endocrinology and metabolism 2002;87(1):148-51.
2001: Lourdes Ibáñez; Ken Ong; Neus Potau; Maria Victoria Marcos; Francis de Zegher; David D Dunger
Insulin gene variable number of tandem repeat genotype and the low birth weight, precocious pubarche, and hyperinsulinism sequence.
The Journal of clinical endocrinology and metabolism 2001;86(12):5788-93.
2001: Kathy Michelmore; Ken Ong; S Mason; S Bennett; L Perry; M Vessey; Adam H Balen; David D Dunger
Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight.
Clinical endocrinology 2001;55(4):439-46.
2000: Ken Ong; Jürgen Kratzsch; Wieland Kiess; M Costello; C Scott; David D Dunger
Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood.
The Journal of clinical endocrinology and metabolism 2000;85(11):4266-9.
2000: Lourdes Ibáñez; Neus Potau; Ken Ong; David D Dunger; Francis de Zegher
Increased bone mineral density and serum leptin in non-obese girls with precocious pubarche: relation to low birthweight and hyperinsulinism.
Hormone research 2000;54(4):192-7.
1999: K Casteels; Ken Ong; D Phillips; H Bendall; Marcus E Pembrey
Mitochondrial 16189 variant, thinness at birth, and type-2 diabetes. ALSPAC study team. Avon Longitudinal Study of Pregnancy and Childhood.
Lancet 1999;353(9163):1499-500.